Parmax Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Parmax Pharma	Link Pharma Chem	Colinz Laboratories
Operational Metrics
Financials
5 yr Average ROE	-1068.03 %	1.59 %	4.71 %
5yr average Equity Multiplier	29.23	1.99	1.29
5yr Average Asset Turnover Ratio	1.05	1.33	0.64
5yr Avg Net Profit Margin	-11.29 %	-0.06 %	5.84 %
Price to Book	0.0	0.99	1.32
P/E	0.0	96.2	25.6
5yr Avg Cash Conversion Cycle	-92.25 Days	82.44 Days	-11.59 Days
Inventory Days	69.37 Days	64.96 Days	56.66 Days
Days Receivable	20.01 Days	72.97 Days	42.5 Days
Days Payable	296.94 Days	84.21 Days	89.1 Days
5yr Average Interest Coverage Ratio	-0.77	2.35	11.55
5yr Avg ROCE	-14.3 %	5.35 %	6.71 %
5yr Avg Operating Profit Margin	2.43 %	3.76 %	7.54 %
5 yr average Debt to Equity	10.96	0.49	0.07
5yr CAGR Net Profit	n/a	n/a	18.95 %
5yr Average Return on Assets	-9.05 %	0.6 %	3.68 %
Shareholdings
Promoter Holding	30.8 %	51.49 %	66.0 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0